Viread Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Early Metabolic Effects of Dolutegravir or Tenofovir Alefenamide in Healthy Volunteers
Conditions:   Metabolic Effects;   Weight Gain;   HIV;   Integrase Strand Transfer Inhibitors Interventions:   Drug: Tenofovir alafenamide;   Drug: Dolutegravir Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials